Next, we analyzed the prognostic values of RRM2 and NUSAP1, and we found that overexpression of RRM2 and NUSAP1 was significantly related to poor overall survival (Fig. 1n and o) and the progression-free interval of PCa patients (Fig. 1p and q). The gene discussed is RRM2; the disease is posterior cortical atrophy.